Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$275M |
| 2 |
Marathon Petroleum
MPC
|
+$188M |
| 3 |
Microsoft
MSFT
|
+$163M |
| 4 |
Salesforce
CRM
|
+$151M |
| 5 |
Williams Companies
WMB
|
+$132M |
Top Sells
| 1 |
Apple
AAPL
|
+$544M |
| 2 |
ANDV
Andeavor
ANDV
|
+$249M |
| 3 |
GGP
GGP Inc.
GGP
|
+$177M |
| 4 |
XL
XL Group Ltd.
XL
|
+$170M |
| 5 |
Spectrum Brands
SPB
|
+$86.7M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Financials | 15.33% |
| 3 | Healthcare | 14.16% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
ADMA Biologics
ADMA
$3.76B
| $1.5M | ﹤0.01% |
242,112
+41,002
| +20% | +$255K |
|
3002
Superior Group of Companies
SGC
$187M
| $1.5M | ﹤0.01% |
78,894
+3,242
| +4% | +$61.6K |
|
3003
Gyre Therapeutics
GYRE
$742M
| $1.5M | ﹤0.01% |
18,503
-3,755
| -17% | -$303K |
|
|
CAJ
3004
DELISTED
Canon, Inc.
CAJ
| $1.49M | ﹤0.01% |
47,132
+4,290
| +10% | +$136K |
|
|
TBCH
3005
Turtle Beach Corporation Common Stock
TBCH
$297M
| $1.49M | ﹤0.01% |
74,701
+7,751
| +12% | +$154K |
|
3006
Kopin
KOPN
$344M
| $1.49M | ﹤0.01% |
615,055
+22,460
| +4% | +$54.3K |
|
3007
Prudential
PUK
$35.5B
| $1.48M | ﹤0.01% |
33,345
-5,353
| -14% | -$238K |
|
|
LEAF
3008
DELISTED
Leaf Group Ltd.
LEAF
| $1.48M | ﹤0.01% |
148,378
+9,821
| +7% | +$98.2K |
|
3009
Cibus
CBUS
$73M
| $1.48M | ﹤0.01% |
1,936
+101
| +6% | +$77.1K |
|
3010
Spyre Therapeutics
SYRE
$977M
| $1.48M | ﹤0.01% |
6,171
+275
| +5% | +$65.8K |
|
|
PCMI
3011
DELISTED
PCM, Inc
PCMI
| $1.48M | ﹤0.01% |
75,478
+10,285
| +16% | +$201K |
|
|
IVH
3012
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
| $1.47M | ﹤0.01% |
103,397
+5,311
| +5% | +$75.7K |
|
3013
Stratus Properties
STRS
$154M
| $1.47M | ﹤0.01% |
48,144
+2,343
| +5% | +$71.7K |
|
|
IOTS
3014
DELISTED
Adesto Technologies Corporation Common Stock
IOTS
| $1.47M | ﹤0.01% |
246,662
+107,470
| +77% | +$639K |
|
3015
DHI Group
DHX
$143M
| $1.47M | ﹤0.01% |
698,246
+35,282
| +5% | +$74K |
|
|
TTPH
3016
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.46M | ﹤0.01% |
26,499
+1,054
| +4% | +$58.2K |
|
3017
Inseego
INSG
$199M
| $1.46M | ﹤0.01% |
37,918
+13,160
| +53% | +$506K |
|
3018
Frontline
FRO
$5.02B
| $1.45M | ﹤0.01% |
250,426
+26,355
| +12% | +$153K |
|
|
VIVS
3019
VivoSim Labs, Inc. Common Stock
VIVS
$8.4M
| $1.45M | ﹤0.01% |
5,267
+274
| +5% | +$75.6K |
|
3020
WisdomTree India Earnings Fund ETF
EPI
$2.93B
| – | – |
0
| – | – |
|
|
TBHC
3021
The Brand House Collective, Inc. Common Stock
TBHC
$44.2M
| $1.45M | ﹤0.01% |
143,461
+3,960
| +3% | +$39.9K |
|
|
CALA
3022
DELISTED
Calithera Biosciences, Inc
CALA
| $1.45M | ﹤0.01% |
13,771
+587
| +4% | +$61.6K |
|
3023
Clearfield
CLFD
$456M
| $1.44M | ﹤0.01% |
106,815
+3,637
| +4% | +$48.9K |
|
3024
NACCO Industries
NC
$293M
| $1.43M | ﹤0.01% |
43,814
+3,511
| +9% | +$115K |
|
3025
Crawford & Co Class B
CRD.B
$483M
| $1.43M | ﹤0.01% |
155,662
+4,657
| +3% | +$42.9K |
|